Skip to main content

Enter a phrase above to search within the site.

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Older Adults

The size of the older adult population is increasing rapidly. Alcohol use among older adults is also increasing . Data from the National Survey on Drug Use and Health indicate that approximately 20 percent of adults aged 60-64 and around 10 percent over age 65 report current binge drinking. Older adults can experience a variety of problems from drinking alcohol...

COGA Distribution Agreement

NIAAA/COGA DATA AND BIOMATERIALS DISTRIBUTION AGREEMENT-- WAVE I and WAVE II WHEREAS, the national Institute on Alcohol Abuse and Alcoholism ("NIAAA") pursuant to its public health mission to identify and characterize the genetic basis of alcohol-related disorders supports research projects in which there is collection by scientific investigators and their relatives; WHEREAS, anonymous blood samples obtained from Wave I and/or...

News Release

NIH study finds hospitalizations increase for alcohol and drug overdoses
For Release

Hospitalizations for alcohol and drug overdoses – alone or in combination – increased dramatically among 18- to 24-year-olds between 1999 and 2008, according to a study by researchers at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health. Led by Aaron M. White, Ph.D. and Ralph W. Hingson, Sc.D., of NIAAA’s division of...

NIAAA Protocol NCIG 006: A Randomized, Double Blind, Placebo-Controlled Trial of the Safety and Efficacy of HORIZANT® (Gabapentin Enacarbil) Extended-Release Tablets for the Treatment of Alcohol Use Disorder
Description This large, multisite clinical trial evaluated the efficacy and safety of gabapentin enacarbil extended-release (GE-XR) (HORIZANT®), a gabapentin prodrug formulation for the treatment of alcohol use disorder (AUD). Study Details Sponsor: The National Institute on Alcohol Abuse and Alcoholism’s Clinical Investigations Group (NCIG) NCT #: 02252536 Phase: Phase 2 Treatment Arms: Horizant® (gabapentin enacarbil) 600mg twice a day and...

Announcement

Presidential Proclamation -- National Alcohol and Drug Addiction Recovery Month, 2015
Every day, resilient Americans with substance use disorders summon extraordinary courage and strength and commit to living healthy and productive lives through recovery. From big cities to small towns to Indian Country, substance use disorders affect the lives of millions of Americans. This month, we reaffirm our unwavering commitment to all those who are seeking or in need of treatment...
Table 2-1. Prevalence of cigarette use, any illicit drug use, marijuana use, and nonmedical use of prescription drugs in the past 30 days among current drinkers, females ages 15–44, by age group, 3-year moving annual averages, 2002–2015.
Substance Use Category and Year Age 15-44 (Total) 15-17 18-20 21-25 26-34 35-44 Percent S.E. Percent S.E. Percent S.E. Percent S.E. Percent S.E. Percent S.E. Cigarette use 2013–2015 27.5 0.4 24.1 1.3 32.7 1.0 29.8 0.9 30.1 0.7 24.6 0.7 2012–2014 29.1 0.4 27.0 1.2 35.1 0.9 31.5 0.7 32.0 0.8 25.2 0.7 2011–2013 30.3 0.4 30.9 1.1 37.8 0.9...
Table 2-2. Prevalence of cigarette use, any illicit drug use, marijuana use, and nonmedical use of prescription drugs in the past 30 days among current drinkers, females ages 15–44, by race/Hispanic origin, 3-year moving annual averages, 2002–2015
Substance Use Category and Year Race/Hispanic Origin Non-Hispanic White Non-Hispanic Black Non-Hispanic Other Hispanic Percent S.E. Percent S.E. Percent S.E. Percent S.E. Cigarette use 2013–2015 29.1 0.5 28.5 1.1 22.1 1.3 22.6 0.8 2012–2014 31.0 0.4 27.8 1.1 23.9 1.6 24.2 1.0 2011–2013 32.7 0.5 27.2 1.1 24.9 1.7 24.7 1.1 2010–2012 33.3 0.6 28.1 1.1 26.5 1.7 26.9 1.2...
Levetiracetam Study
Data Access Policy, Application and Agreement NIAAA Protocol NCIG 002: A Multisite Double-Blind, Placebo-Controlled Trial of Levetiracetam Extended-Release in Very Heavy-Drinking Alcohol-Dependent Patients Description This multisite clinical trial evaluated the efficacy and safety of levetiracetam XR, for the treatment of alcohol use disorder (AUD). Study Details Sponsor: The National Institute on Alcohol Abuse and Alcoholism’s Clinical Investigations Group (NCIG) NCT #...
Council Clearance for IND-enabling Small Business NOFO
Title: Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use Disorder and Alcohol-Associated Organ Damage (AAOD) Authors : Jenica Patterson, Ph.D; Megan Ryan, M.B.A.; Raye Litten, Ph.D.; Kathy Jung, Ph.D. Purpose: DTR intends to re-issue PAR 18-578 “Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use Disorder and Alcohol-Related Organ Damage (U44)”...

Advisory Council Minutes

National Advisory Council Meeting - February 4-5, 2009

Summary of the 120th Meeting February 4-5, 2009 The National Advisory Council on Alcohol Abuse and Alcoholism convened for its 120th meeting at 5:30 p.m. on February 4, 2009, at the FishersLaneConferenceCenter in Rockville, Maryland, in a closed session. Dr. Abraham Bautista presided over the closed review of grant applications. The NIAAA National Advisory Council reconvened in closed session on...

Alcohol Treatment in the United States
Prevalence of Past-Year Alcohol Use Treatment People Ages 12 and Older According to the 2022 National Survey on Drug Use and Health (NSDUH), 2.2 million people ages 12 and older who had alcohol use disorder (AUD) in the past year (7.6% of people with past-year AUD in this age group) received alcohol use treatment in the past year. 1,2 This...

Advisory Council Minutes

Minutes of the 139th Meeting of the NATIONAL ADVISORY COUNCIL ON ALCOHOL ABUSE AND ALCOHOLISM

DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM 139th Meeting of the NATIONAL ADVISORY COUNCIL ON ALCOHOL ABUSE AND ALCOHOLISM June 10 , 2015 The National Advisory Council on Alcohol Abuse and Alcoholism (NIAAA) convened for its 139th meeting at 9:00 a.m. on Wednesday, June 10, 2015, at NIAAA headquarters in...

Our Staff

The National Institute on Alcohol Abuse and Alcoholism’s leadership and staff support and promote the mission of the Institute every day. Learn more about our leadership and organization: Leadership Director’s Page Organization Offices and Divisions Organizational Chart

News Release

NIH study identifies gene for alcohol preference in rats
For Release

Selectively bred strains of laboratory rats that either prefer or avoid alcohol have been a mainstay of alcohol research for decades. So-called alcohol-preferring rats voluntarily consume much greater amounts of alcohol than do non-preferring rats. Scientists at the National Institutes of Health now report that a specific gene plays an important role in the alcohol-consuming tendencies of both types of...

News Release

Male and female drinking patterns becoming more alike in the U.S.
For Release

In the United States, and throughout the world, men drink more alcohol than women. But a recent analysis by scientists at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, indicates that longstanding differences between men and women in alcohol consumption and alcohol-related harms might be narrowing in the United States. Researchers led...

Looking for U.S. government information and services?
Visit USA.gov